Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396990 · ClinicalTrials.gov registry record · Phase 4
The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study
A Phase 4 study, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04396990 is a Phase 4 study that has completed, run by Vance Thompson Vision. The registered enrollment target is 20 participants.
The verdict
NCT04396990, a Phase 4 study, has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral PRK surgery.
Interventions
- DRUG Topical Prednisolone
- DRUG Dextenza 0.4Mg Ophthalmic Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-06-08 |
| Est. Completion | 2020-09-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04396990
The ClinicalTrials.gov registry entry for NCT04396990 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical Prednisolone is the first listed.
NCT04396990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04396990 about?
NCT04396990 is a clinical study titled "The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study". To determine patient preference and treatment outcomes with an intracanalicular dexamethasone (0.4mg) insert compared to standard steroid drop regimen in the contralateral eye following bilateral PRK surgery.
What is the current status of trial NCT04396990?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2020-06-08. Estimated completion is 2020-09-28.
What interventions are being tested in trial NCT04396990?
The interventions under investigation include: Topical Prednisolone (DRUG), Dextenza 0.4Mg Ophthalmic Insert (DRUG).
Who is sponsoring clinical trial NCT04396990?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.